3 challenges the Apple Watch needs to overcome to succeed in health care
After the insurmountable buzz, the Apple Watch was finally released last week. Within its first day of pre-orders, Apple secured more sales than all of the Android smartwatch manufacturers combined in 2014, according to Forbes.
As popular as it is with consumers and Apple fanatics, should doctors and health care executives be just as impressed? And more importantly, could the Apple Watch become as indispensable as a stethoscope in the future?
According to Michael DeFranco, a thought leader in the mobile workforce revolution, the use of smartwatches for messaging in health care has the potential to solve a number of issues plaguing the industry.
A study conducted by the Ponemon Institute also found that 39 percent of health care professionals believe time is wasted by not using text messaging. The study also revealed that inefficient communication triples admission time, doubles emergency response time for each patient, and costs a hospital an estimated $1.7 million per year in wasted time.
While DeFranco believes that smartwatch adoption offers the opportunity for advances in the health care industry, he noted three key challenges that first need to be addressed before smartwatches and the Apple Watch are accepted industry-wide.
Smartwatches need to be paired with a phone and therefore there are concerns about interference with equipment in intensive care units or operating rooms. Multiple hospitals have policies prohibiting the use of mobile phones in these rooms so policies would need to be reviewed and updated if the Apple Watch were to be accepted.
Watches are notoriously hard to clean—pair that with sensitive technology and you’ve got an even bigger problem at hand. All health care professionals are known for their hand washing and cleanliness, so a smartwatch needs to be just as particular. Whether this means UV disinfection or alternate methods, this is a critical thought to consider.
3. Battery Life
Finally, DeFranco notes battery life as a primary challenge for smartwatch adoption. The Apple Watch currently offers a battery life of 18 hours after a full charge, but there are a number of variables that could affect this—including making phone calls.
“While the battery life should be sufficient for most people, healthcare providers relying on it for important messages may find it insufficient as the number of notifications they receive throughout a typical day may be much higher than the average user,” states DeFranco.
For those three reasons, this is why DeFranco and numerous other health care leaders do not see the Apple Watch and other smartwatches being adopted by the industry—right now, at least. While better patient care and more efficient communication is always the goal, these challenges need to be addressed first.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”